Sentinel Node Status and Survival in Melanoma Patients
Author Information
Author(s): Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E
Primary Institution: University of Vienna
Hypothesis
Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
Conclusion
The study found that sentinel lymph node status does not significantly correlate with overall survival in melanoma patients.
Supporting Evidence
- Sentinel lymph nodes were identified in 299 of 309 patients, with a success rate of 96.8%.
- 69 patients had a positive sentinel lymph node, leading to a recurrence rate of 36.2%.
- The 3-year overall survival was 93% for sentinel node-negative patients compared to 83% for sentinel node-positive patients.
- Multivariate analysis showed that sentinel node status was not a significant predictor of overall survival.
Takeaway
Doctors check a special lymph node to see if melanoma has spread, but this study shows it doesn't always help predict how long patients will live.
Methodology
The study involved performing sentinel lymph node biopsies on 309 melanoma patients and analyzing survival outcomes using statistical methods.
Potential Biases
Potential biases may arise from the selection of patients and the methods used for identifying sentinel nodes.
Limitations
The study's follow-up period was relatively short, which may affect the overall survival findings.
Participant Demographics
The mean age of participants was 55.8 years, with 58% male and a range of melanoma types and stages.
Statistical Information
P-Value
p<0.001
Confidence Interval
1.010–1.127
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website